Logo image of IGIC

INTERNATIONAL GENERAL INSURA (IGIC) Stock Fundamental Analysis

NASDAQ:IGIC - Nasdaq - BMG4809J1062 - Common Stock - Currency: USD

23.32  -0.68 (-2.83%)

After market: 23.45 +0.13 (+0.56%)

Fundamental Rating

4

Taking everything into account, IGIC scores 4 out of 10 in our fundamental rating. IGIC was compared to 143 industry peers in the Insurance industry. IGIC has an average financial health and profitability rating. IGIC has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IGIC was profitable.
Each year in the past 5 years IGIC has been profitable.
Of the past 5 years IGIC 4 years had a positive operating cash flow.
IGIC Yearly Net Income VS EBIT VS OCF VS FCFIGIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

IGIC has a better Return On Assets (6.06%) than 90.91% of its industry peers.
IGIC has a better Return On Equity (18.86%) than 88.11% of its industry peers.
Industry RankSector Rank
ROA 6.06%
ROE 18.86%
ROIC N/A
ROA(3y)5.96%
ROA(5y)4.59%
ROE(3y)20.44%
ROE(5y)15.82%
ROIC(3y)N/A
ROIC(5y)N/A
IGIC Yearly ROA, ROE, ROICIGIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

IGIC has a Profit Margin of 22.91%. This is amongst the best in the industry. IGIC outperforms 95.80% of its industry peers.
In the last couple of years the Profit Margin of IGIC has grown nicely.
Looking at the Operating Margin, with a value of 23.13%, IGIC belongs to the top of the industry, outperforming 89.51% of the companies in the same industry.
IGIC's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.13%
PM (TTM) 22.91%
GM N/A
OM growth 3Y19.8%
OM growth 5Y21.84%
PM growth 3Y25.11%
PM growth 5Y19.24%
GM growth 3YN/A
GM growth 5YN/A
IGIC Yearly Profit, Operating, Gross MarginsIGIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

4

2. Health

2.1 Basic Checks

IGIC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IGIC has been increased compared to 1 year ago.
IGIC has less shares outstanding than it did 5 years ago.
IGIC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IGIC Yearly Shares OutstandingIGIC Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
IGIC Yearly Total Debt VS Total AssetsIGIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

IGIC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.04%
IGIC Yearly LT Debt VS Equity VS FCFIGIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
IGIC Yearly Current Assets VS Current LiabilitesIGIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

3

3. Growth

3.1 Past

IGIC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.92%.
Measured over the past years, IGIC shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.48% on average per year.
IGIC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.90%.
The Revenue has been growing by 18.58% on average over the past years. This is quite good.
EPS 1Y (TTM)-13.92%
EPS 3Y43.92%
EPS 5Y43.48%
EPS Q2Q%-52.81%
Revenue 1Y (TTM)5.9%
Revenue growth 3Y15.01%
Revenue growth 5Y18.58%
Sales Q2Q%13.71%

3.2 Future

IGIC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.04% yearly.
Based on estimates for the next years, IGIC will show a decrease in Revenue. The Revenue will decrease by -6.47% on average per year.
EPS Next Y-11.75%
EPS Next 2Y-0.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-18.25%
Revenue Next 2Y-6.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IGIC Yearly Revenue VS EstimatesIGIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
IGIC Yearly EPS VS EstimatesIGIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.57 indicates a reasonable valuation of IGIC.
Compared to the rest of the industry, the Price/Earnings ratio of IGIC indicates a somewhat cheap valuation: IGIC is cheaper than 73.43% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.93. IGIC is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 7.32, the valuation of IGIC can be described as very cheap.
Based on the Price/Forward Earnings ratio, IGIC is valued a bit cheaper than 72.73% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 37.78. IGIC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.57
Fwd PE 7.32
IGIC Price Earnings VS Forward Price EarningsIGIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IGIC is valued a bit cheaper than the industry average as 65.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.15
IGIC Per share dataIGIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

IGIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.2
EPS Next 2Y-0.04%
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

IGIC has a yearly dividend return of 0.83%, which is pretty low.
IGIC's Dividend Yield is slightly below the industry average, which is at 3.29.
Compared to an average S&P500 Dividend Yield of 2.32, IGIC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.83%

5.2 History

IGIC has been paying a dividend for over 5 years, so it has already some track record.
IGIC has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
IGIC Yearly Dividends per shareIGIC Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

DPN/A
EPS Next 2Y-0.04%
EPS Next 3YN/A
IGIC Yearly Income VS Free CF VS DividendIGIC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

INTERNATIONAL GENERAL INSURA

NASDAQ:IGIC (7/28/2025, 8:00:02 PM)

After market: 23.45 +0.13 (+0.56%)

23.32

-0.68 (-2.83%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05
Inst Owners44.08%
Inst Owner Change-0.45%
Ins Owners38.11%
Ins Owner ChangeN/A
Market Cap1.04B
Analysts87.5
Price Target32.64 (39.97%)
Short Float %0.83%
Short Ratio1.62
Dividend
Industry RankSector Rank
Dividend Yield 0.83%
Yearly Dividend0.59
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-Date06-02 2025-06-02 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.71%
Min EPS beat(2)-10.49%
Max EPS beat(2)17.91%
EPS beat(4)3
Avg EPS beat(4)10.43%
Min EPS beat(4)-10.49%
Max EPS beat(4)17.91%
EPS beat(8)7
Avg EPS beat(8)21.29%
EPS beat(12)10
Avg EPS beat(12)38.94%
EPS beat(16)13
Avg EPS beat(16)35.14%
Revenue beat(2)2
Avg Revenue beat(2)28.2%
Min Revenue beat(2)6.99%
Max Revenue beat(2)49.41%
Revenue beat(4)2
Avg Revenue beat(4)8.17%
Min Revenue beat(4)-16.1%
Max Revenue beat(4)49.41%
Revenue beat(8)4
Avg Revenue beat(8)3.75%
Revenue beat(12)5
Avg Revenue beat(12)-4.48%
Revenue beat(16)6
Avg Revenue beat(16)-8.5%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-12.5%
EPS NQ rev (3m)-23.91%
EPS NY rev (1m)-2.65%
EPS NY rev (3m)-5.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-34.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-21.4%
Valuation
Industry RankSector Rank
PE 8.57
Fwd PE 7.32
P/S 1.93
P/FCF N/A
P/OCF N/A
P/B 1.59
P/tB 1.59
EV/EBITDA 7.15
EPS(TTM)2.72
EY11.66%
EPS(NY)3.19
Fwd EY13.67%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.08
BVpS14.67
TBVpS14.67
PEG (NY)N/A
PEG (5Y)0.2
Profitability
Industry RankSector Rank
ROA 6.06%
ROE 18.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 23.13%
PM (TTM) 22.91%
GM N/A
FCFM N/A
ROA(3y)5.96%
ROA(5y)4.59%
ROE(3y)20.44%
ROE(5y)15.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y19.8%
OM growth 5Y21.84%
PM growth 3Y25.11%
PM growth 5Y19.24%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)121.22%
Cap/Depr(5y)104.5%
Cap/Sales(3y)0.74%
Cap/Sales(5y)0.7%
Profit Quality(3y)169.81%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.92%
EPS 3Y43.92%
EPS 5Y43.48%
EPS Q2Q%-52.81%
EPS Next Y-11.75%
EPS Next 2Y-0.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.9%
Revenue growth 3Y15.01%
Revenue growth 5Y18.58%
Sales Q2Q%13.71%
Revenue Next Year-18.25%
Revenue Next 2Y-6.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.38%
EBIT growth 3Y37.78%
EBIT growth 5Y44.48%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.9%
FCF growth 3Y5.47%
FCF growth 5Y58.39%
OCF growth 1Y6.54%
OCF growth 3Y6.12%
OCF growth 5Y57.81%